HOLLY BRIGANCE: Open Payments
NPI 1730332511 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 41 payments from 9 companies in 2025. Trend: 2023 $946 · 2024 $745 · 2025 $849
Food & beverage: $674Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 12 | $316 |
| AstraZeneca Pharmaceuticals LP | 11 | $239 |
| Novo Nordisk Inc | 4 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Phathom Pharmaceuticals, Inc. | 6 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Lundbeck LLC | 1 | $34 |
| ABBVIE INC. | 1 | $17 |
| PFIZER INC. | 1 | $14 |
Products named: AIRSUPRA, PROLIA, OTEZLA, REXULTI, VOQUEZNA, BREZTRI, GEMTESA, Ozempic.
Industry payments across AR — which companies pay providers there.
